In-Licensing Opportunity

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

Assessment of dissolvable microneedle technology along with Identification of Top Licensing Partner Companies through Secondary and Primary Intelligence.

Problem Statement:

A large client based in the USA, involved in drug delivery devices, with effective marketing and commercialisation presence across the globe, wanted to in-license potential dMTS based drug delivery asset from companies involved in microneedle technology research for delivering therapeutic products. They wished to identify and assess the technological competencies, clinical capabilities and commercial readiness of potential companies with a novel and non-invasive way of delivering drugs, which can include a variety of drugs/vaccines in their patch and successfully develop the product for commercial purposes, were of client’s interest.

Our Methodology:
  • dMTS Market Assessment
  • Companies Assessment
  • Technology Assessment
  • Investment Assessment
  • Primary Assessment
  • Strategic Insights on Companies
  • Assessment of own company
  • Strategic Goal Building
  • Matrix Analysis positioned the top 20 companies researched.
  • The client could assess the Top companies which would effectively fit their strategic needs and objectives (the TARGET quadrant).
  • DelveInsight fixed meetings with these probably 4-5 companies for the client to take discussions forward.

Related Insights

Pipeline Assessment
Pipeline Assessment

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. [...]

View Case
Market Assessment
Market Assessment

A global pharmaceutical company wished to evaluate the market value of an asset obtained by acquiring a mid-cap company. The new class of drug showed the potential in targeting multiple... [...]

View Case
Go-To-Market Strategy
Go-To-Market Strategy

A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.